“主动健康”下的慢性阻塞性肺疾病中医特色疗法研究

Research on the traditional Chinese medicine characteristic therapy of chronic obstructive pulmonary disease under active health strategy

关键词:  主动健康  慢性阻塞性肺疾病  肺肾气虚证  中医特色疗法  临床研究

Key words:  active health strategy  COPD  lung and kidney qi deficiency syndrome  traditional Chinese medicine characteristic therapy  clinical study

摘要:

[目的] 评价中医特色疗法治疗慢性阻塞性肺疾病稳定期肺肾气虚证的疗效。[方法] 符合纳入标准的80例慢性阻塞性肺疾病稳定期肺肾气虚证患者。随机分为西医常规治疗组（40例）和中医特色治疗组（40例）。常规治疗组患者给予沙美特罗替卡松粉吸入剂50 μg/250 μg（舒利迭）吸入治疗，中医特色治疗组在前者基础上给予中医特色肺康复疗法，包括中药口服+经典穴位贴敷+中药离子导入。疗程各为2个月，分3段治疗，总疗程6个月。随访第6个月，评价两组患者治疗前后的肺功能、急性加重次数、慢性阻塞性肺疾病评估测试（CAT）评分变化、西医症状积分、中医症状积分。[结果] 两组患者治疗后急性加重次数、CAT评分、西医症状积分较治疗前有所降低（P<0.05或P<0.01）；中医特色治疗组患者FEV1较常规治疗组稍有改善（P<0.05），且可以降低患者的中医症状积分。[结论] 中医特色治疗可一定程度延缓慢性阻塞性肺疾病患者肺功能下降，减少患者急性加重次数，改善患者的疾病状态。

Abstract:

[Objective] To evaluate the therapeutic effect of traditional Chinese medicine(TCM) characteristic therapy on chronic obstructive pulmonary disease (COPD) in the stable period of lung and kidney qi deficiency. [Methods] The inclusion criteria were met in 80 patients with COPD at stable stage of pulmonary lung and kidney qi deficiency. The patients were randomly divided into conventional Western medicine treatment group (40 cases) and traditional Chinese medicine characteristic treatment group (40 cases). The patients in the conventional treatment group were given salmeteroticasone inhalant 50 μg/250 μg (Supratide). On the basis of the former,the patients in the TCM characteristic treatment group were given TCM characteristic pulmonary rehabilitation therapy,including TCM oral administration + classical acupoint application + TCM ion introduction. Each course of treatment is 2 months,divided into 3 treatment stages;the total course of treatment is 6 months. At the 6th month of follow-up,pulmonary function,number of acute exacerbations,changes in CAT score,western medicine symptom score and traditional Chinese medicine syndrome score of the two groups were evaluated before and after treatment. [Results] The number of acute exacerbations,CAT score and western medicine symptom score after treatment were decreased in both groups (P<0.05 or P<0.01). FEV1 in the TCM characteristic treatment group was slightly improved compared with the conventional treatment group (P<0.05),and could reduce the TCM syndrome score of the patients. [Conclusion] The characteristic treatment of TCM can delay the decline of pulmonary function in patients with COPD to some extent,reduce the number of patients with acute aggravation,and improve the disease status of patients.